Camp4 Therapeutics (CAMP) Enterprise Value (2023 - 2025)
Camp4 Therapeutics (CAMP) has disclosed Enterprise Value for 3 consecutive years, with -$110.9 million as the latest value for Q4 2025.
- Quarterly Enterprise Value fell 73.12% to -$110.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$110.9 million through Dec 2025, down 73.12% year-over-year, with the annual reading at -$110.9 million for FY2025, 73.12% down from the prior year.
- Enterprise Value hit -$110.9 million in Q4 2025 for Camp4 Therapeutics, down from -$75.3 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$2.5 million in Q3 2024 to a low of -$110.9 million in Q4 2025.
- Historically, Enterprise Value has averaged -$53.8 million across 3 years, with a median of -$49.9 million in 2023.
- Biggest five-year swings in Enterprise Value: surged 94.99% in 2024 and later plummeted 2878.64% in 2025.
- Year by year, Enterprise Value stood at -$38.4 million in 2023, then plummeted by 66.86% to -$64.0 million in 2024, then tumbled by 73.12% to -$110.9 million in 2025.
- Business Quant data shows Enterprise Value for CAMP at -$110.9 million in Q4 2025, -$75.3 million in Q3 2025, and -$39.1 million in Q2 2025.